Key Points
- EVP Haitao Cui sold 3,291 shares on March 20 at an average price of $4.54 for roughly $14,941, leaving him with 133,307 shares (a 2.41% reduction in his position).
- He also sold 156 shares on March 18 and 603 shares on March 19, for a total of 4,050 shares sold across March 18–20.
- Foxx Development has a market cap of about $29.9 million, negative EPS (P/E -1.89), trades near its 50‑day moving average ($4.54), and carries a consensus "Sell" rating amid ~60% institutional ownership (including a small Citadel stake).
Foxx Development Holdings Inc. (NASDAQ:FOXX - Get Free Report) EVP Haitao Cui sold 3,291 shares of the company's stock in a transaction that occurred on Friday, March 20th. The shares were sold at an average price of $4.54, for a total value of $14,941.14. Following the completion of the transaction, the executive vice president directly owned 133,307 shares of the company's stock, valued at $605,213.78. This represents a 2.41% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Haitao Cui also recently made the following trade(s):
- On Wednesday, March 18th, Haitao Cui sold 156 shares of Foxx Development stock. The stock was sold at an average price of $4.50, for a total transaction of $702.00.
- On Thursday, March 19th, Haitao Cui sold 603 shares of Foxx Development stock. The stock was sold at an average price of $4.56, for a total transaction of $2,749.68.
Foxx Development Price Performance
FOXX opened at $4.27 on Thursday. Foxx Development Holdings Inc. has a fifty-two week low of $1.71 and a fifty-two week high of $8.88. The company's 50 day moving average price is $4.54 and its two-hundred day moving average price is $4.40. The firm has a market capitalization of $29.92 million, a price-to-earnings ratio of -1.89 and a beta of -0.28.
Foxx Development (NASDAQ:FOXX - Get Free Report) last released its quarterly earnings results on Friday, February 13th. The company reported ($0.62) earnings per share (EPS) for the quarter. The firm had revenue of $16.72 million for the quarter.
Institutional Investors Weigh In On Foxx Development
A hedge fund recently bought a new stake in Foxx Development stock. Citadel Advisors LLC bought a new position in Foxx Development Holdings Inc. (NASDAQ:FOXX - Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 12,025 shares of the company's stock, valued at approximately $57,000. Citadel Advisors LLC owned approximately 0.18% of Foxx Development as of its most recent filing with the Securities and Exchange Commission (SEC). Hedge funds and other institutional investors own 60.44% of the company's stock.
Wall Street Analyst Weigh In
Separately, Weiss Ratings reissued a "sell (e+)" rating on shares of Foxx Development in a research note on Monday, December 29th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has an average rating of "Sell".
Get Our Latest Research Report on FOXX
Foxx Development Company Profile
(
Get Free Report)
Foxx Development, Inc (NASDAQ: FOXX) operates as a contract manufacturer specializing in the design, assembly and distribution of medical devices and components. The company's core business centers on phlebotomy and blood collection products, serving clinical laboratories, hospitals and diagnostic testing facilities. Its product portfolio includes evacuated blood collection tubes, safety-engineered winged blood collection sets, syringes and ancillary devices used in specimen collection and handling.
Founded in North Carolina, Foxx Development maintains a manufacturing and distribution campus in Apex, where it integrates engineering, quality control and regulatory compliance under one roof.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
